Replies to post #444946 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Going by this EU Regulatory procedures for a marketing authorisation (MA), Anavex would be in the first row "Pre-submission - Actions" of the table.

Given the PR says:

announced today that the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) agreed that oral blarcamesine for Alzheimer’s disease is eligible for submission of an application for a Union Marketing Authorisation in the EU under the European Medicines Agency’s centralised procedure

I would say Anavex is well through that first row now working on the MAA submission for the technical validation.

[ExtremelyBullishZig]

Do you have any evidence that they didn't?